Holdings
Fairmount Funds Management LLC
As of Jun 30, 2026, Fairmount Funds Management LLC reported 12 positions worth US$1.51B. Largest: Oruka Therapeutics, Inc., Dianthus Therapeutics, Inc. and Damora Therapeutics, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Oruka Therapeutics, Inc. | 3.71M | US$353M | no change | Jun 30, 2026 |
| Dianthus Therapeutics, Inc. | 2.54M | US$247M | no change | Jun 30, 2026 |
| Damora Therapeutics, Inc. | 8.71M | US$227M | no change | Jun 30, 2026 |
| Cogent Biosciences, Inc. | 5.5M | US$213M | no change | Jun 30, 2026 |
| Jade Biosciences, Inc. | 4.55M | US$101M | no change | Jun 30, 2026 |
| Enliven Therapeutics, Inc. | 1.86M | US$94.2M | no change | Jun 30, 2026 |
| Viridian Therapeutics, Inc. | 5.09M | US$93.5M | +1.18M | Jun 30, 2026 |
| Zenas Biopharma, Inc. | 2.36M | US$59.9M | no change | Jun 30, 2026 |
| Crescent Biopharma, Inc. | 2.75M | US$49.5M | no change | Jun 30, 2026 |
| Apogee Therapeutics, Inc. | 299K | US$39.6M | no change | Jun 30, 2026 |